Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
PharmaNew Brunswick, New Jersey, United States · Est. 1886 · 135,000 employees
Johnson & Johnson is a diversified healthcare company with a leading pharmaceutical research and development division focused on innovative medicines across multiple therapeutic areas.
0
Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
0
Indications↗
Distinct diseases across all programs
455
Clinical Trials↗
All sponsored trials (all statuses)
Activity
Key Events
Details
Company Info
Company Overview
$380.0B
Mkt Cap
$94.9B
Revenue
—
Cash
CEOJoaquin Duato
Founded1886
Employees135,000
HQNew Brunswick, New Jersey, United States
Websitejnj.com
LinkedInCompany Page
Therapeutic Focus
OncologyImmunologyCardiovascularInfectious Disease
Recent SEC Filings
8-KAug 4, 2026
8-K
8-KJul 29, 2026
8-K
8-KJul 28, 2026
8-K
8-KJul 15, 2026
8-K
Regulatory
Regulatory Timeline
19821 event
FDAJan 1
Meclan — MECLAN
Application NDA050518 (NDA)
20264 events
SECAug 4
8-K
Accession: 0000200406-26-000167
SECJul 29
8-K
Accession: 0000200406-26-000163
SECJul 28
8-K
Accession: 0000200406-26-000155
SECJul 15
8-K
Accession: 0000200406-26-000146
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)